SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (187)1/11/2003 12:05:00 AM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
DCGN Was up 41.43% on volume of 1,593,445 (about 14.6x its daily average) after it and Roche announced they had found genetic variations associated with higher risk of developing osteoporosis and JP Morgan raised its rating from "neutral" to "overweight".<g>

The stock did not close its initial up-gap.

siliconinvestor.com

And closed near its intra-day H and and above its November 27 H of 2.79

siliconinvestor.com

From a longer term perspective the stock seems to have enough room to run.<g>

siliconinvestor.com

Bernard



To: Jibacoa who wrote (187)1/13/2003 3:13:50 PM
From: JMarcus  Read Replies (1) | Respond to of 3722
 
<<Will see if the shares [of CRDM] can close today above $1.25.(That would be higher than its Hs since last July.)>>

We closed lower than your goal last Friday (at $1.18, to be precise), but we've been above $1.25 most of today, in a trading range between $1.26 and $1.30.

finance.yahoo.com

Marc